Polaris Partners

Overview

Polaris Partners provides venture investment and active board-level support to biotechnology and healthcare companies, helping entrepreneurs develop products, run clinical programs, and scale businesses for commercial use.

Part of the Boston ecosystem

Related

• AsimovAsimov designs and delivers integrated cells, genetic constructs, and cloud software to enable commercial-grade cell line and viral vector development for biologics and cell therapies.
• Atlas VentureAtlas Venture builds biotechnology companies by partnering with life science entrepreneurs to translate scientific research into medicines for patients with medical needs.
• Beam Therapeutics ($BEAM)Beam Therapeutics develops precision genetic medicines using base editing and delivery technologies to create investigational therapies for patients with genetic diseases and to support clinical applications.
• Flagship PioneeringFlagship Pioneering invents, incubates, and builds biology-driven companies that develop novel medicines, engineered crops, and AI-enabled life‑science platforms for healthcare and agriculture customers.
• Ginkgo Bioworks ($DNA)Ginkgo Bioworks designs and deploys autonomous laboratory systems and services that automate experimental workflows for biotechnology projects, supporting drug discovery, biologics screening, and industrial R&D customers.
• LabCentralLabCentral provides shared laboratory space, startup resources, pathway programs, workshops, events, and media for early-stage life science startups and people entering biotech careers.
• Life BiosciencesLife Biosciences develops epigenetic cellular rejuvenation therapies intended to restore aged or damaged cell function for patients with aging-related diseases, including optic neuropathies.
• Material ImpactMaterial Impact builds and backs inception-stage deep tech companies using materials science, supporting founders developing products aimed at urgent human needs and cleaner, healthier industries.
• Moderna ($MRNA)Moderna develops and tests messenger RNA (mRNA) medicines and vaccines, designing sequences and running clinical programs for therapeutic and preventive use in patients and healthcare systems.
• Pillar VCPillar VC invests at inception in technical breakthrough startups, supporting founders building healthcare AI, programmable biology, generative homebuilding, and other research-driven companies.
• Prime Medicine ($PRME)Prime Medicine develops and applies Prime Editing gene‑editing technology to locate and replace disease-causing DNA sequences, creating precise edits for therapeutic programs aimed at patients with genetic disorders.
• Vertex Pharmaceuticals ($VRTX)Vertex Pharmaceuticals discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about clinical trial opportunities.